Rebecca Killion, MA
Articles
November 13th 2018
Understanding and Improving Value Frameworks With Real-World Patient Outcomes
Anupam B. Jena, MD, PhD Jacquelyn W. Chou, MPP, MPL Lara Yoon, MPH Wade M. Aubry, MD Jan Berger, MD, MJ Wayne Burton, MD A. Mark Fendrick, MD Donna M. Fick, RN, PhD David Franklin, BA Rebecca Killion, MA Darius N. Lakdawalla, PhD Peter J. Neumann, ScD Kavita Patel, MD, MSHS John Yee, MD, MPH Brian Sakurada, PharmD Kristina Yu-Isenberg, PhD, MPH, RPh
New value frameworks should incorporate real-world evidence that reflects patient treatment behavior, adherence to medication, and equity concerns arising from disparities in care.
September 30th 2013
Improving Patient-Centered Care in Diabetes With Comparative Effectiveness Research
Douglas K. Owens, MD Wade Aubry, MD Roy Beck, MD Joshua Benner, MD Jan E. Berger, PharmD Michael E. Chernew, PhD Felicia Forma, BSc Dana P. Goldman, PhD William H. Herman, MD Rebecca Killion, MA Darius Lakdawalla, PhD Anne L Peters, MD
July 2nd 2013
Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes
Michael E. Chernew, PhD Rick McKellar, BS Wade Aubry, MD Roy Beck, MD, PhD Joshua Benner, PharmD, ScD Jan E. Berger, MD, MJ A. Mark Fendrick, MD Felicia Forma, BSc Dana Goldman, PhD Anne Peters, MD Rebecca Killion, MA Darius Lakdawalla, PhD Douglas K. Owens, MD Joe Stahl, MA
February 12th 2013
Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes
Michael E. Chernew, PhD Rick McKellar, BS Wade Aubry, MD Roy Beck, MD, PhD Joshua Benner, PharmD, ScD Jan E. Berger, MD, MJ A. Mark Fendrick, MD Felicia Forma, BSc Dana Goldman, PhD Anne Peters, MD Rebecca Killion, MA Darius Lakdawalla, PhD Douglas K. Owens, MD Joe Stahl, MA
Formularies of the future should use evidence-produced CER to better target, not limit, diabetes care.
